Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Apply
CABA-201
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step